Veterinary Medicines Information website

DRAINOSYL SOLUTION BUVABLE

Authorised
  • TARAXACUM OFFICINALE D3
  • BERBERIS VULGARIS C3
  • SOLIDAGO VIRGAUREA C3
  • CHINA D3
  • Hydrastis canadensis C3
  • Cynara scolymus D3
  • SILYBUM MARIANUM C3
  • Chelidonium majus C5
Download as PDF

Product identification

Medicine name:
DRAINOSYL SOLUTION BUVABLE
Active substance:
  • TARAXACUM OFFICINALE D3
  • BERBERIS VULGARIS C3
  • SOLIDAGO VIRGAUREA C3
  • CHINA D3
  • Hydrastis canadensis C3
  • Cynara scolymus D3
  • SILYBUM MARIANUM C3
  • Chelidonium majus C5
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Equid
  • Sheep
  • Goat
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • TARAXACUM OFFICINALE D3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • BERBERIS VULGARIS C3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • SOLIDAGO VIRGAUREA C3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • CHINA D3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Hydrastis canadensis C3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Cynara scolymus D3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • SILYBUM MARIANUM C3
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
  • Chelidonium majus C5
    0.13
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • All relevant tissues
        0
        day
    • Pig
      • All relevant tissues
        0
        day
    • Rabbit
      • All relevant tissues
        0
        day
    • Equid
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Goat
      • All relevant tissues
        0
        day
    • Poultry
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boiron
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/2245672 4/2012
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/01/2026
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/01/2026
Download